Sargent Investment Group, LLC Revance Therapeutics, Inc. Transaction History
Sargent Investment Group, LLC
- $449 Million
- Q1 2024
A detailed history of Sargent Investment Group, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 12,895 shares of RVNC stock, worth $33,140. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,895
Previous 13,822
6.71%
Holding current value
$33,140
Previous $121,000
47.93%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
214Shares Held
83.4MCall Options Held
656KPut Options Held
424K-
Capital World Investors Los Angeles, CA13.9MShares$35.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.31MShares$18.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.28MShares$16.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$13.9 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.25MShares$13.5 Million3.02% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...